爱尔兰爵士制药的去纤维钠售价多少？

On October 22, 2013, Ireland's Jazz Pharmaceuticals was approved by the EU for marketing as the first treatment for severe hepatic veno-occlusive disease in adults and children undergoing hematopoietic stem cell transplantation. On March 30, 2016, the U.S. Food and Drug Administration (FDA) approved defibrotide (sodium defibrotide) for the treatment of hepatic veno-occlusive disease (VOD) caused by hematopoietic stem cell transplantation in adults and children with renal and pulmonary dysfunction. Defibrinoside (Defibrotide) is the first and only treatment for severe hepatic veno-occlusive disease.

In clinical trials, heparin was used to prevent diseases such as hepatic venous occlusion while greatly increasing the risk of bleeding. However, Irish Jazz alone or in combination with heparin has a very low incidence of side effects and has achieved a good effect in preventing HVOD. In a phase III multi-center randomized clinical trial completed in Europe, a total of 356 stem cell transplant patients were recruited. When comparing the incidence of hepatic vein occlusion 30 days after transplantation, 2 of 180 patients in the Irish Jazz group developed hepatic vein occlusion, accounting for 12%; 35 of 176 patients in the control group developed hepatic vein occlusion, accounting for 20%.

Ireland's Jazz Pharmaceuticals is a commercial-stage biopharmaceutical company engaged in the identification, development and commercialization of pharmaceutical products. Irish Jazz Pharmaceuticals' defibrotide sodium is the first drug approved by the FDA for the treatment of severe hepatic venous occlusion, a rare and fatal liver disease. How much does Irish Jazz Pharmaceuticals' defibrinated sodium cost?

The price of Irish Jazz Pharmaceuticals exported to different countries is different. Medical Travel has sorted out the price of Defitelio sodium sold in Turkey: the price of 200mg is about $22,000.

Recommended related hot articles: /newsDetail/92890.html